Showing results (471-480 of 513) with videos related to

Sort By:
Pageof 52
Scientific Reports|February 3, 2018
Dysregulated fibronectin trafficking by Hsp90 inhibition restricts prostate cancer cell invasionHeather K Armstrong, Joanna L Gillis, Ian R D Johnson, et al.
Nature Communications|September 30, 2025
Best practices and tools in R and Python for statistical processing and visualization of lipidomics and metabolomics dataJakub Idkowiak, Jonas Dehairs, Jana Schwarzerová, et al.
International Journal of Cancer|October 6, 2018
An analysis of a multiple biomarker panel to better predict prostate cancer metastasis after radical prostatectomyAlison Y Zhang, Karen Chiam, Ygal Haupt, et al.
Prostate Cancer and Prostatic Diseases|March 13, 2026
Lipidomic profiling in metastatic prostate cancer captures tumor metabolic rewiring and its modulation by androgen receptor-targeting therapySara Bleve, Francesco Ravera, Silvia Rodrigues, et al.
Cancer Letters|January 4, 2025
Metabolic reprogramming, malignant transformation and metastasis: Lessons from chronic lymphocytic leukaemia and prostate cancerMadison T Hindes, Anthony M McElligott, Oliver G Best, et al.
Cancer Research|April 24, 2024
ACSM1 and ACSM3 Regulate Fatty Acid Metabolism to Support Prostate Cancer Growth and Constrain FerroptosisRaj K Shrestha, Zeyad D Nassar, Adrienne R Hanson, et al.
Cell Death & Disease|June 2, 2026
USP2 is an androgen-repressed survival factor that stabilises oncoproteins to facilitate therapy resistance in prostate cancerDanielle Meiwen Fang, Raj K Shrestha, Beatriz German, et al.
Biorxiv : the Preprint Server for Biology|April 3, 2026
Suppression of de novo lipogenesis and dietary PUFA supplementation inhibit prostate cancer progressionSilvia D Rodrigues, Caroline Fidalgo Ribeiro, Giuseppe N Fanelli, et al.
Elife|July 21, 2020
Human DECR1 is an androgen-repressed survival factor that regulates PUFA oxidation to protect prostate tumor cells from ferroptosisZeyad D Nassar, Chui Yan Mah, Jonas Dehairs, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 9, 2018
The Magnitude of Androgen Receptor Positivity in Breast Cancer Is Critical for Reliable Prediction of Disease OutcomeCarmela Ricciardelli, Tina Bianco-Miotto, Shalini Jindal, et al.
Pageof 52